You are now leaving GSK’s website

This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites controlled by third-parties.

Continue

Go back

Find out information about our rare diseases products, including prescribing and safety information.

Products in our rare diseases portfolio:

  • Strimvelis (Autologous CD34+ enriched cell fraction transduced to encode for human adenosine deaminase (ADA).

Strimvelis is a registered trademark of the GlaxoSmithKline group of companies